One-Third of U.S. Adults Could Have Diabetes by 2050: CDC

One-Third of U.S. Adults Could Have Diabetes by 2050: CDC
FRIDAY, Oct. 22 (HealthDay News) — The number of American adults with diabetes could double or triple by 2050 if current trends continue, warns a federal government study released Friday.
Read more on HealthDay via Yahoo! News

Neurowave Medical Technologies™ Introduces Reletex™, A Neuromodulation Device To Relieve Post-Operative Nausea
Neurowave Medical Technologies™ announced the release of an innovative new device for the treatment of post-operative nausea, medically referred to as emesis. Reletex™ is a novel transdermal neuromodulation device that is non-invasive and drug-free, and has been demonstrated to alleviate nausea when used as an adjunct to anti-emetics. Reletex is a neuromodulation device worn on the wrist that …
Read more on Medical News Today

Dr. Jeffrey Moses Assumes Expanded Role in Interventional Cardiology, Leading New Bi-Campus Program at NewYork …
Dr. Jeffrey W. Moses, an internationally recognized leader in clinical innovation and research, is assuming an expanded role as director of interventional cardiology at NewYork-Presbyterian Hospital. The new program spans the Hospital’s two major medical centers — NewYork-Presbyterian Hospital/Columbia University Medical Center and NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
Read more on Newswise